Biotech Investor Strüngmann: "Zero Opportunities in Germany"

Frankfurt His first big financial coup is a few years back. In 2005, Thomas Strüngmann and his twin brother Andreas sold the generic drug manufacturer Hexal to the Basel-based pharmaceutical…

Opel, Merck, Privacy: The corporate events of the week

DusseldorfWith the annual general meetings of Sixt, Rocket Internet, Xing, Hawesko and Rhön-Klinikum, the season of shareholder meetings is slowing down this week. But there are new exciters. More than…

Morning Briefing by Hans-Jürgen Jakobs

Good morning dear readers, somehow that seems like potential threat of the US President Donald Trump not to catch. Somehow his supposed art seems to be fast deal to make…